FDA Inspection 773429 — S.A.E.G.

S.A.E.G. — FEI 3003492947

The FDA completed an inspection of S.A.E.G. on March 19, 2012 in Owingsville, KY. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 13 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
March 19, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Owingsville, KY (United States)

Citations

IDCFRDescription
111121 CFR 211.25(a)Training , Education , Experience overall
115921 CFR 211.28(a)Clothing appropriate for duties performed
136121 CFR 211.100(a)Absence of Written Procedures
172821 CFR 211.87Retest of approved components/containers/closures
176721 CFR 211.137(a)Expiration date lacking
180121 CFR 211.84(a)Components withheld from use pending release
188321 CFR 211.165(a)Testing and release for distribution
256921 CFR 211.198(b)Maintenance of Complaint File
355921 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
356321 CFR 211.56(c)Rodenticides et. al. registration and usage
358521 CFR 211.110(a)Control procedures to monitor and validate performance
433821 CFR 211.150(b)Recall facilitation
900121 CFR 211.22(a)Lack of quality control unit